HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1674994Generated: October 31, 2026
Benzoyl chloride, 3-chloro- → 6-[4-[5-(3-Chlorophenyl)-1,2,4-oxadiazol-3-yl]piperazin-1-yl]-3-(trifluoromethyl)[1,2,4]triazolo[4,3-b]pyridazine
https://huagongshe.com/reaction/1674994
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Benzoyl chloride, 3-chloro- | HCID 69252 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | HCID 178513432 | HCID 178513432 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | 6-[4-[5-(3-Chlorophenyl)-1,2,4-oxadiazol-3-yl]piperazin-1-yl]-3-(trifluoromethyl)[1,2,4]triazolo[4,3-b]pyridazine | HCID 59149707 | — |
Reaction Steps
3-Chlorobenzoyl chloride (92 mg, 0.53 mmol) was added to a stirred partial solution of N-hydroxy-4-[3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperazine-1-carboximidamide (165 mg, 0.5 mmol) and DIPEA (97 mg, 0.75 mmol) in THF (3 mL). The reaction mixture became a clear solution over 30 minutes and LCMS after 1 hour showed complete initial acylation. The reaction mixture was heated at 150° C. for 15 minutes by microwave after which LCMS showed complete cyclisation to the desired product. The reaction mixture was evaporated and the residue was boiled briefly with ethanol, cooled and filtered off to give 6-[4-[5-(3-chlorophenyl)-1,2,4-oxadiazol-3-yl]piperazin-1-yl]-3-(trifluoromethyl)[1,2,4]triazolo[4,3-b]pyridazine (104 mg, 46%) as a crystalline powder.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08003649B2 |
|---|
| Source dataset | uspto-grants-2011_08 |
|---|
| ORD ID | ord-1caba17b6a3a400baf8bca5012137c66 |
|---|
| Source note | uspto-grants-2011_08 |
|---|